E
Calliditas Therapeutics AB (publ) CALT
NASDAQ
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2024 03/31/2024 12/31/2023 09/30/2023 06/30/2023
Net Income -45.43M -49.73M -44.00M -42.61M -27.90M
Total Depreciation and Amortization 1.56M 1.56M 1.56M 1.21M 1.21M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 19.30M 10.44M 8.84M 7.94M 817.10K
Change in Net Operating Assets 1.20M -475.60K -7.74M 11.46M -2.18M
Cash from Operations -23.37M -38.20M -41.33M -22.01M -28.06M
Capital Expenditure -1.20M -1.20M -1.20M -234.50K -234.50K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -85.80K -177.00K -84.70K -968.30K -366.20K
Cash from Investing -1.29M -1.38M -1.29M -1.20M -600.80K
Total Debt Issued 962.89M 962.89M 962.89M 255.28M 255.28M
Total Debt Repaid -740.16M -739.11M -736.61M -11.73M -11.41M
Issuance of Common Stock 14.00K -- -- 31.48M 31.48M
Repurchase of Common Stock -- -- -- 0.00 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -26.63M -26.63M -26.63M -1.26M -1.26M
Cash from Financing 18.44M 18.53M 18.77M 25.55M 25.57M
Foreign Exchange rate Adjustments -492.40K 1.55M -2.47M 1.66M 3.92M
Miscellaneous Cash Flow Adjustments -100.00 -200.00 -100.00 100.00 100.00
Net Change in Cash -6.71M -19.49M -26.32M 4.00M 836.50K
Weiss Ratings